Magellan Rx Management’s Live Vibrantly: Whole Health Program Leverages Behavioral Health and Opioid Management
September 25 2019 - 6:30AM
Business Wire
Program improves patient outcomes and reduces
cost of care
Magellan Rx Management, a division of Magellan Health, Inc.
(NASDAQ: MGLN), offers an innovative, integrated approach to
improving healthcare and cost of care outcomes with Live Vibrantly:
Whole Health.
This solution focuses on behavioral health and opioid
management, utilizing specially trained clinical pharmacists with
certifications in pain management and psychiatry. Through Live
Vibrantly: Whole Health, pharmacists work face-to-face with
providers to equip them with the tools and resources necessary to
make informed decisions regarding treatment plans for their
patients. The program also focuses on quality measures that are
important to providers and clients including HEDIS® measures around
adherence, appropriate laboratory monitoring, and overuse of
medications like opioids and antipsychotics.
“Our program is centered on the quality of care in prescribing
medications for members with complex conditions that require
behavioral health medications and opioids,” said Caroline Carney,
MD, MSc, FAPM, CPHQ, chief medical officer, Magellan Rx Management.
“In focusing on avoiding polypharmacy, overly high doses, and
dangerous combinations of drugs, we improve outcomes and save
lives.”
Improved Behavioral Health Outcomes
According to SAMHSA, over 47 million Americans live with a
mental health condition and serious mental illness costs Americans
$193.2 billion in lost earnings per year1. As a result of
implementing the Live Vibrantly: Whole Health program, one health
plan customer reduced overall utilization of behavioral health
medications and significantly improved the recommended metabolic
screenings for members taking antipsychotics which is also a HEDIS
measure. Over a three month evaluation period:
- 67 percent reduction in the number of members taking multiple
(six or more) behavioral health medications resulting in an average
reduction of one behavioral medication per impacted member;
- 46 percent of impacted members were no longer taking two or
more atypical antipsychotic medications; and
- 110 percent increase in the number of members on antipsychotics
receiving recommended metabolic screenings.
“The personal attention and individualized patient focus from a
clinical pharmacist really sets the Whole Health program apart from
the rest,” said Ilan Melnick, MD, chief medical officer, Passageway
Residencies of Dade County. “The program recognized the specific
needs of my patients and we were able to collaborate in order to
optimize medication management, as gaps or delays in treatment may
create a downward spiral in a fragile population.”
Addressing Inappropriate Opioid Prescribing
In addition to behavioral health results, the program was
implemented with another health plan customer to address
inappropriate opioid prescribing. Opioid abuse is another crisis in
the United States, resulting in more than 130 deaths from overdose
every day2. Following a six month evaluation period, significant
gaps were addressed and closed through the use of the program:
- 97 percent of individuals engaged in doctor/pharmacy shopping
(at least three doctors and three pharmacies) no longer engaged in
that practice with an average reduction of two prescribers and one
pharmacy per member;
- 73 percent of impacted members no longer received opioids at
high doses reducing the average morphine milligram equivalents
(MME) per person per claim from 97.9 to 63.2; and
- 85 percent of members were no longer on the combination of a
high dose opioid medication and a benzodiazepine.
“Through the Live Vibrantly: Whole Health program, our
pharmacists work collaboratively with providers in the communities
they serve to close gaps in care and consult on complex patient
cases,” said Crystal Henderson, PharmD, BCPP, senior director,
behavioral health pharmacy solutions, Magellan Rx Management. “This
program helps providers better understand prescribing patterns that
put members at risk for adverse outcomes and drive high costs of
care. By working with providers, we help their members’ lead
healthier, vibrant lives.”
-
https://www.nami.org/learn-more/mental-health-by-the-numbers
-
https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis
About Magellan Rx Management: Magellan Rx Management, a
division of Magellan Health, Inc., is a full-service,
next-generation pharmacy benefit manager (PBM) that helps our
customers and members solve complex pharmacy challenges by
connecting them to the people, technology, and information they
need to make smarter healthcare decisions. As experts in managing
specialty spend both on the prescription and medical benefit, we
are energized by discovering new and better ways to deliver
solutions in today’s complex and rapidly-evolving healthcare
environment, leading people to live healthier, more vibrant
lives.
About Magellan Health: Magellan Health, Inc., a Fortune
500 company, is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through
technology, while remaining focused on the critical personal
relationships that are necessary to achieve a healthy, vibrant
life. Magellan's customers include health plans and other managed
care organizations, employers, labor unions, various military and
governmental agencies and third-party administrators. For more
information, visit MagellanHealth.com.
(MGLN-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190925005225/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com,
(860) 507-1923 Investor Contact: Joe Bogdan,
jbogdan@magellanhealth.com, (860) 507-1910
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Apr 2023 to Apr 2024